BioAge Labs

BioAge Labs is a leading biotechnology research company focused on harnessing the biology of human aging to develop innovative targets and therapies for metabolic diseases. Located at Primary: 1445A S 50th St, Richmond, CA 94804, US, BioAge Labs is dedicated to unlocking novel biological insights and creating druggable mechanisms for age-related conditions. The company's commitment to innovation drives its pursuit of groundbreaking solutions in the field of metabolic health.

BioAge Labs' proprietary platform encompasses an extensive range of molecular measurements that span decades of human aging. This platform enables the company to identify key pathways and develop targeted interventions. BioAge Labs' lead program, azelaprag, holds promise as a potential first-in-class oral APJ agonist. Currently entering Phase 2 trials in combination with tirzepatide, azelaprag aims to treat obesity in older adults by amplifying weight loss and improving body composition when used with incretin drugs.

BioAge Labs is committed to advancing metabolic aging research through its preclinical programs, which are based on unique insights from its human longevity data. The company strives to maintain its position at the forefront of biotechnology, contributing significantly to the development of novel therapies. We invite the manager of BioAge Labs to create a customized and exclusive company showcase and product listing on our platform, enhancing visibility and commercial opportunities.